Certolizumab Pegol

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AB05

CAS registry number (Chemical Abstracts Service)

0428863-50-7

Chemical Formula

C2115-H3252-N556-O673-S16

Therapeutic Categories

Immunosuppressant

Monoclonal antibody

Tumor necrosis factor alpha (TNF-α) inhibitor

Foreign Names

• Certulizumabum pegolum (Latin)
• Certulizumab pegol (German)
• Certulizumab pégol (French)
• Certulizumab pegol (Spanish)

Generic Names

• Certolizumab Pegol (OS: USAN, BAN)
• CDP870 (IS: UCB)
• PHA-738144 (IS)

Brand Names

• Cimizia
  UCB, France



• Cimzia
  UCB, Germany; UCB, Finland; UCB, Sweden; UCB, United States; UCB Pharma, United Kingdom; UCB-Pharma, Switzerland

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.